EP 166: Developing targeted therapies for ALS with Eric Green from Trace Neuroscience, Maze Therapeutics, and Stanford University - Trace Neuroscience

Trace Neuroscience

About ALS
Our Focus
Our Team
Clinical Trials

12/19/2024

Share

Clinical Trials
Home
Privacy Policy
Terms of Service